Abstract:Schematic overview of VDAC1+/+ and VDAC1+/− model: Working model for the regulation of mitophagy, mitochondrial dynamics, mitochondrial biogenesis, VDAC1, and Hexokinase interaction, and VDAC1 and P‐Tau interaction. In VDAC1+/+, (i) dissociation of hexokinase (HK) results in a "closed" VDAC configuration that prevents adenine nucleotide exchange and uncouples intra and extramitochondrial metabolism, (ii) shifts the equilibrium to the VDAC1 oligomeric state, mediating the release of apoptogenic proteins and leading to apoptosis, (iii) Elevated GSK3β activity is a key event in phosphorylation of Tau and synaptic pathology in AD. GSK3β is proposed to activate VDAC1 phosphorylation, ultimately leading to mitochondrial dysfunction and synaptic damage in AD, (iv) Defective mitophagy, (v) increased mitochondrial fission and decreased mitochondrial fusion. In VDAC1+/− (i) VDAC1 and ANT reportedly interact directly when complexed with HK, an arrangement that facilitates mitochondrial contact site formation and metabolite exchange, (ii) decreased GSK3β and P‐Tau activity, and (iii) PINK1 recruits PARKIN from the cytoplasm to mitochondrial outer membrane. After PARKIN has been recruited to mitochondria, activated PARKIN ubiquitinates proteins in the mitochondrial outer membrane VDAC to facilitate mitophagy. PARKIN‐mediated ubiquitination recruits autophagy adapter protein p62, and these proteins interact with LC3B. LC3B participates in the formation of an autophagosome, which is fated for lysosomal destruction to clear out damaged mitochondrion, (iv) decreased mitochondrial fission and increased mitochondrial fusion. Alzheimer's disease (AD) is the most common cause of mental dementia in the aged population. AD is characterized by the progressive decline of memory and multiple cognitive functions, and changes in behavior and personality. Recent research has revealed age‐dependent increased levels of VDAC1 in postmortem AD brains and cerebral cortices of APP, APPxPS1, and 3xAD.Tg mice. Further, we found abnormal interaction between VDAC1 and P‐Tau in the AD brains, leading to mitochondrial structural and functional defects. Our current study aimed to understand the impact of a partial reduction of voltage‐dependent anion channel 1 (VDAC1) protein on mitophagy/autophagy, mitochondrial and synaptic activities, and behavior changes in transgenic TAU mice in Alzheimer's disease. To determine if a partial reduction of VDAC1 reduces mitochondrial and synaptic toxicities in transgenic Tau (P301L) mice, we crossed heterozygote VDAC1 knockout (VDAC1+/−) mice with TAU mice and generated double mutant (VDAC1+/−/TAU) mice. We assessed phenotypic behavior, protein levels of mitophagy, autophagy, synaptic, other key proteins, mitochondrial morphology, and dendritic spines in TAU mice relative to double mutant mice. Partial reduction of VDAC1 rescued the TAU‐induced behavioral impairments such as motor coordination and exploratory behavioral changes, and learning and spatial memory impairments in VDAC1+/−/TAU mice. Protein levels of mitophagy, autophagy, and synaptic proteins were significantly increased in double mutant mice compared with TAU mice. In addition, dendritic spines were significantly increased; the mitochondrial number was significantly reduced, and mitochondrial length was increased in double mutant mice. Based on these observations, we conclude that reduced VDAC1 is beneficial in symptomatic‐transgenic TAU mice.

TAU ablation in excitatory neurons and postnatal TAU knockdown reduce epilepsy, SUDEP, and autism behaviors in a Dravet syndrome model

Defects in the autophagy lysosomal pathway in a cell model of disease‐associated tau

Excitoprotective effects of conditional tau reduction in excitatory neurons and in adulthood

Tau Reduction Prevents Key Features of Autism in Mouse Models

Tau reduction affects excitatory and inhibitory neurons differently, reduces excitation/inhibition ratios, and counteracts network hypersynchrony

Targeted Reducing of Tauopathy Alleviates Epileptic Seizures and Spatial Memory Impairment in an Optogenetically Inducible Mouse Model of Epilepsy

Tau depletion in human neurons mitigates Aβ-driven toxicity

Hyperactive neuronal networks facilitate tau spread in an Alzheimer's disease mouse model

Stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau in cellular and mouse models of tauopathies

Neuronal Levels and Sequence of Tau Modulate the Power of Brain Rhythms

Effects of P301L-TAU on post-translational modifications of microtubules in human iPSC-derived cortical neurons and TAU transgenic mice

Tau reduction attenuates autism-like features in Fmr1 knockout mice

Abnormal increased mTOR signaling regulates seizure threshold in Dravet syndrome

Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration

Targeting Tau Mitigates Mitochondrial Fragmentation and Oxidative Stress in Amyotrophic Lateral Sclerosis

Knockdown of TTLL1 reduces Aβ-induced TAU pathology in human iPSC-derived cortical neurons

Tauopathy in the young autistic brain: novel biomarker and therapeutic target

Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (Asf)-Regulated Alternative Splicing of Tau in Down Syndrome

Enhanced Fyn-tau and NR2B-PSD95 interactions in epileptic foci in experimental models and human epilepsy

A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic Tau mouse model

Hyperexcitability precedes CA3 hippocampal neurodegeneration in a dox-regulatable TDP-43 mouse model of ALS-FTD.